Literature DB >> 19031005

Production of recombinant albumin by a herd of cloned transgenic cattle.

Yann Echelard1, Jennifer L Williams, Margaret M Destrempes, Julie A Koster, Susan A Overton, Daniel P Pollock, Karen T Rapiejko, Esmail Behboodi, Nicholas C Masiello, William G Gavin, Jerry Pommer, Scott M Van Patten, David C Faber, Jose B Cibelli, Harry M Meade.   

Abstract

Purified plasma derived human albumin has been available as a therapeutic product since World War II. However, cost effective recombinant production of albumin has been challenging due to the amount needed and the complex folding pattern of the protein. In an effort to provide an abundant source of recombinant albumin, a herd of transgenic cows expressing high levels of rhA in their milk was generated. Expression cassettes efficiently targeting the secretion of human albumin to the lactating mammary gland were obtained and tested in transgenic mice. A high expressing transgene was transfected in primary bovine cell lines to produce karyoplasts for use in a somatic cell nuclear transfer program. Founder transgenic cows were produced from four independent cell lines. Expression levels varying from 1-2 g/l to more than 40 g/l of correctly folded albumin were observed. The animals expressing the highest levels of rhA exhibited shortened lactation whereas cows yielding 1-2 g/l had normal milk production. This herd of transgenic cattle is an easily scalable and well characterized source of rhA for biomedical uses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19031005     DOI: 10.1007/s11248-008-9229-9

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  49 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  The farmyard drug store.

Authors: 
Journal:  Nature       Date:  2006-09-07       Impact factor: 49.962

3.  Cloned transgenic calves produced from nonquiescent fetal fibroblasts.

Authors:  J B Cibelli; S L Stice; P J Golueke; J J Kane; J Jerry; C Blackwell; F A Ponce de León; J M Robl
Journal:  Science       Date:  1998-05-22       Impact factor: 47.728

4.  Albumin. 1. Background and use.

Authors:  J L Tullis
Journal:  JAMA       Date:  1977-01-24       Impact factor: 56.272

5.  Transgenic production from in vivo-derived embryos: effect on calf birth weight and sex ratio.

Authors:  E Behboodi; W Groen; M M Destrempes; J L Williams; C Ohlrichs; W G Gavin; D M Broek; C A Ziomek; D C Faber; H M Meade; Y Echelard
Journal:  Mol Reprod Dev       Date:  2001-09       Impact factor: 2.609

Review 6.  In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.

Authors:  R C Stadalnik; M Kudo; W C Eckelman; D R Vera
Journal:  Invest Radiol       Date:  1993-01       Impact factor: 6.016

7.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Production of goats by somatic cell nuclear transfer.

Authors:  A Baguisi; E Behboodi; D T Melican; J S Pollock; M M Destrempes; C Cammuso; J L Williams; S D Nims; C A Porter; P Midura; M J Palacios; S L Ayres; R S Denniston; M L Hayes; C A Ziomek; H M Meade; R A Godke; W G Gavin; E W Overström; Y Echelard
Journal:  Nat Biotechnol       Date:  1999-05       Impact factor: 54.908

9.  Production of cystic fibrosis transmembrane conductance regulator in the milk of transgenic mice.

Authors:  P DiTullio; S H Cheng; J Marshall; R J Gregory; K M Ebert; H M Meade; A E Smith
Journal:  Biotechnology (N Y)       Date:  1992-01

Review 10.  Transgenic milk as a method for the production of recombinant antibodies.

Authors:  D P Pollock; J P Kutzko; E Birck-Wilson; J L Williams; Y Echelard; H M Meade
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

View more
  20 in total

1.  The creation of transgenic pigs expressing human proteins using BAC-derived, full-length genes and intracytoplasmic sperm injection-mediated gene transfer.

Authors:  Masahito Watanabe; Mayuko Kurome; Hitomi Matsunari; Kazuaki Nakano; Kazuhiro Umeyema; Akira Shiota; Hiromitsu Nakauchi; Hiroshi Nagashima
Journal:  Transgenic Res       Date:  2011-10-25       Impact factor: 2.788

Review 2.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 3.  Transgenic bovine as bioreactors: Challenges and perspectives.

Authors:  Paulo S Monzani; Paulo R Adona; Otávio M Ohashi; Flávio V Meirelles; Matthew B Wheeler
Journal:  Bioengineered       Date:  2016-05-11       Impact factor: 3.269

4.  The extremely high level expression of human serum albumin in the milk of transgenic mice.

Authors:  Xiaojie Wu; Yanli Lin; Fuyin Xiong; Yanrong Zhou; Fang Yu; Jixian Deng; Peitang Huang; Hongxing Chen
Journal:  Transgenic Res       Date:  2012-03-24       Impact factor: 2.788

Review 5.  Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules.

Authors:  Isabelle Legastelois; Sophie Buffin; Isabelle Peubez; Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Hum Vaccin Immunother       Date:  2016-12-01       Impact factor: 3.452

6.  Production of transgenic cattle highly expressing human serum albumin in milk by phiC31 integrase-mediated gene delivery.

Authors:  Yan Luo; Yongsheng Wang; Jun Liu; Hui Lan; Minghao Shao; Yuan Yu; Fusheng Quan; Yong Zhang
Journal:  Transgenic Res       Date:  2015-07-22       Impact factor: 2.788

7.  Production of transgenic cattle expressing lysine-rich polypeptide in milk by somatic cell nuclear transfer.

Authors:  Sheng Zhang; Xin Ma; Zhongwei Wang; Peng Zhang; Ziyi Li
Journal:  Transgenic Res       Date:  2019-03-26       Impact factor: 2.788

8.  The construction and expression of lysine-rich gene in the mammary gland of transgenic mice.

Authors:  Xin Ma; Peng Zhang; Guangqi Song; Yue Chen; Zhongwei Wang; Yupeng Yin; Delong Kong; Sheng Zhang; Zhihui Zhao; Hongsheng Ouyang; Bo Tang; Ziyi Li
Journal:  DNA Cell Biol       Date:  2012-05-11       Impact factor: 3.311

9.  Use of transgenic animals in biotechnology: prospects and problems.

Authors:  O G Maksimenko; A V Deykin; Yu M Khodarovich; P G Georgiev
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

10.  Engineering protein processing of the mammary gland to produce abundant hemophilia B therapy in milk.

Authors:  Jianguo Zhao; Weijie Xu; Jason W Ross; Eric M Walters; Stephen P Butler; Jeff J Whyte; Lindsey Kelso; Mostafa Fatemi; Nicholas C Vanderslice; Keith Giroux; Lee D Spate; Melissa S Samuel; Cliff N Murphy; Kevin D Wells; Nick C Masiello; Randall S Prather; William H Velander
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.